Studies on several tumors, including glioblastoma [38], EC [39], lung cancer [40], and prostate cancer [41], showed that when APOE is overexpressed, the disease is more aggressive, and the prognosis is poor [42]. The gene discussed is APOE; the disease is prostate carcinoma.